Abstract
Three patients with hemiballismus received intravenous flumazenil and placebo in a double-blind cross-over study aimed to investigate whether an antagonistic action at the level of the GABA-benzodiazepine receptors may improve choreoballistic movements. No clinical benefit was seen.
Publication types
-
Clinical Trial
-
Controlled Clinical Trial
MeSH terms
-
Aged
-
Aged, 80 and over
-
Cross-Over Studies
-
Double-Blind Method
-
Female
-
Flumazenil / therapeutic use*
-
GABA Antagonists / therapeutic use*
-
Humans
-
Movement Disorders / drug therapy*
-
Placebos
Substances
-
GABA Antagonists
-
Placebos
-
Flumazenil